NAUT NASDAQ
Credit Risk of going bust: higher than 84% of companies Debt: 8.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.05 (down 98%), Nautilus Biotechnolgy, Inc. would be worth roughly what it owes.
Total debt $27.8M against a stock market value of $310.5M.
Distance to default 2.20 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $13.9M (short-term plus half of long-term), stock volatility 119.8%; Altman Z'' -2.17. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Seattle, WA 98102
US
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Posard Matthew L. | A-Award | 45,000 | $2.28 | 2026-06-18 |
| NAZEM FARZAD | A-Award | 45,000 | $2.28 | 2026-06-18 |
| Akinsanya Karen | A-Award | 45,000 | $2.28 | 2026-06-18 |
| McIlwain Matthew S | A-Award | 45,000 | $2.28 | 2026-06-18 |
| Epperly Melissa B, | A-Award | 45,000 | $2.28 | 2026-06-18 |